Navigation Links
SPACED COVER GLASS S (22X24 MM) from Takara Mirus Bio

ProductsSPACED COVER GLASS S (22X24 MM) from Takara Mirus Bio
Company Takara Mirus Bio
Item SPACED COVER GLASS S (22X24 MM)
Price $111.00
Description Spaced cover glasses to promote effective hybridization
Info Takara Mirus BioTakara Mirus Bio
510 Charmany Drive
Suite 273
Madison, WI 53719 USA

Call Takara Mirus Bio to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-536-4401
Customer Service: (888) 251-6618 or (608) 441-2844
Fax Number: (608) 441-2845
Web Site: http://www.takaramirusbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. DISCOVERLIGHT RABBIT ARRA from Pierce Biotechnology, Inc.
2. DISCOVERLIGHT MOUSE ARRAY from Pierce Biotechnology, Inc.
3. DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
4. DISCOVERLIGHT BIOTIN ARRA from Pierce Biotechnology, Inc.
5. GPDH Assay Kit from Takara Mirus Bio
6. Bgl I from Takara Mirus Bio
7. Mun I (Mfe I) from Takara Mirus Bio
8. BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
9. Acc I from Takara Mirus Bio
10. Sma I (High Concentration) from Takara Mirus Bio
11. Hae III (High Concentration) from Takara Mirus Bio
... Xylene Resistant (X/R) Red System consists ... Red Activator and X/R Red Buffer. ... alkaline phosphatase to produce red staining ... ,Kit Contains:, , Buffer, 100 mL ...
Phospho-YAP (Ser127) Antibody Ship: Hot Store: -20 C...
Mouse Cell Line Slides...
... comprehensive, cost-effective solution to your TechMate ... quality into both our products and ... chemistries and antibodies that have been ... also includes our competitively priced accessories ...
Biology Products:
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
(Date:5/6/2015)... LifeBEAM, a developer of bio-sensing technology, and ... that they will expand their partnership in bio-sensing sports ... helmet and the first joint project between the two ... order to give cyclists more style choices and meet ... Lazer announced their plan to release a new generation ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... GAINESVILLE, Fla. Survival of the fittest has popularly ... new study published in the Royal Society journal Biology ... millions of years may also play a powerful role. ... are the first to link the evolution of proteins ...
... Emory University School of Medicine a three-year grant of more ... that may contribute to the development of autism. Stephen ... Genetics, is principal investigator of the program project that also ... faculty members in human genetics. Autism occurs four ...
... research project, which receives funding from Hope Against ... an extract from bilberries can prevent or delay ... Gescher, of the University of Leicester, is ... with the commercially produced substance Mirtoselect (extracted from ...
Cached Biology News:UF researchers devise way to calculate rates of evolution 2UF researchers devise way to calculate rates of evolution 3Simons Foundation awards Emory scientists $3M for autism gene research 2Bilberry extract -- can it help prevent certain cancers? 2Bilberry extract -- can it help prevent certain cancers? 3
(Date:6/3/2015)... and CHICAGO , June 3, ... or "the Company"; LSE: CIR), a specialty biopharmaceutical company ... data relating to the Company,s novel immunotherapy candidates targeting ... presented at the 2015 European Academy of Allergy and ... Barcelona, Spain on 6-10 June. ...
(Date:6/3/2015)... Virginia (PRWEB) June 03, 2015 Photo-Eyewear™ ... changed its name to PogoTec™, Inc. ( http://www.PogoTec.com ... its electronic wearable device products and technologies it is ... creation of three business divisions, PogoTec™ will provide focused ... devices as follows: , , On-Track™ ...
(Date:6/3/2015)... June 03, 2015 Global Stem ... Inc. have announced plans to conduct Romania’s first ever ... Through an alliance with Miami-based Stem Cell Training, Inc., ... the Adipose and Bone Marrow Stem Cell Training Course ... reconstructive plastic surgery specialist practicing in Bucharest and Tel ...
(Date:6/2/2015)... TapImmune, Inc. (OTCQB: TPIV), a clinical stage cancer immunotherapy ... whereby the institutional investors will have the option to ... up to $4.93M in near term funding, pending closing ... restructured terms and subject to certain market conditions, the ... in a larger influx of capital to fund the ...
Breaking Biology Technology:Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 2Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 3TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 2TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 3